32 related articles for article (PubMed ID: 16416013)
1. Initial screening of the rs104893657 variant of the PAX8 gene in women with hypothyroidism from Northeastern Slovakia.
Mydlárová Blaščáková M; Homjáková B; Nagy M; Poráčová J; Lörinczová Z; Makovický P; Kimáková T; Sedlák V; Konečná M
Cent Eur J Public Health; 2023 Dec; 31(Suppl 1):S89-S94. PubMed ID: 38272482
[TBL] [Abstract][Full Text] [Related]
2. [PROPDESC Score Validation (PROPDESC-Val)].
Guttenthaler V; Kunsorg A; Mayr A; Hering T; Menzenbach J; Wittmann M
Anaesthesiologie; 2024 Jan; 73(1):56-59. PubMed ID: 38172421
[No Abstract] [Full Text] [Related]
3. BCL-2 (-938C>A), BAX (-248G>A), and HER2 Ile655Val Polymorphisms and Breast Cancer Risk in Indian Population.
Bhatt D; Verma AK; Bharti PS; Goyal Y; Alsahli MA; Almatroudi A; Rahmani AH; Almatroodi S; Joshi PC; Alam MM; Ahmad I; Zaman GS; Dev K
J Oncol; 2021; 2021():8865624. PubMed ID: 33708254
[TBL] [Abstract][Full Text] [Related]
4. HER2Ile655Val Single Nucleotide Polymorphism Associated with Early-Onset Breast Cancer Susceptibility: A Systematic Review and Meta-Analysis.
Nguyen Thanh T; Nguyen Tran BS; Hoang Thi AP; Tran Binh T; Ba Nguyen T; Le Minh T; Nguyen Vu QH; Dang Cong T
Asian Pac J Cancer Prev; 2021 Jan; 22(1):11-18. PubMed ID: 33507673
[TBL] [Abstract][Full Text] [Related]
5. Her2
Krishna BM; Chaudhary S; Panda AK; Mishra DR; Mishra SK
Sci Rep; 2018 May; 8(1):7427. PubMed ID: 29743533
[TBL] [Abstract][Full Text] [Related]
6. Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study.
Budiarto BR; Desriani
Sci Pharm; 2016; 84(1):103-11. PubMed ID: 27110502
[TBL] [Abstract][Full Text] [Related]
7. Association of HER2 codon 655 polymorphism with ovarian cancer.
Watrowski R; Castillo-Tong DC; Schuster E; Fischer MB; Speiser P; Zeillinger R
Tumour Biol; 2016 Jun; 37(6):7239-44. PubMed ID: 26666819
[TBL] [Abstract][Full Text] [Related]
8. HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer.
Ozturk O; Canbay E; Kahraman OT; Fatih Seyhan M; Aydogan F; Celik V; Uras C
Mol Biol Rep; 2013 Feb; 40(2):1813-8. PubMed ID: 23086302
[TBL] [Abstract][Full Text] [Related]
9. ErbB2, EphrinB1, Src kinase and PTPN13 signaling complex regulates MAP kinase signaling in human cancers.
Vermeer PD; Bell M; Lee K; Vermeer DW; Wieking BG; Bilal E; Bhanot G; Drapkin RI; Ganesan S; Klingelhutz AJ; Hendriks WJ; Lee JH
PLoS One; 2012; 7(1):e30447. PubMed ID: 22279592
[TBL] [Abstract][Full Text] [Related]
10. ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study.
Qu S; Cai Q; Gao YT; Lu W; Cai H; Su Y; Wang SE; Shu XO; Zheng W
Breast Cancer Res Treat; 2008 Jul; 110(1):169-76. PubMed ID: 17687647
[TBL] [Abstract][Full Text] [Related]
11. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
Kamali-Sarvestani E; Talei AR; Merat A
Cancer Lett; 2004 Nov; 215(1):83-7. PubMed ID: 15374636
[TBL] [Abstract][Full Text] [Related]
12. The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk.
Cox DG; Hankinson SE; Hunter DJ
Pharmacogenet Genomics; 2005 Jul; 15(7):447-50. PubMed ID: 15970791
[TBL] [Abstract][Full Text] [Related]
13. Role of HER-2 Ile655Val Polymorphism as Universal Cancer Susceptibility Marker among Different Cancers.
Riaz SK; Rashid MM; Kayani MA; Arshad Malik MF
Arch Iran Med; 2016 Jun; 19(6):430-8. PubMed ID: 27293060
[TBL] [Abstract][Full Text] [Related]
14. HER-2 [Ile655Val] polymorphism in association with breast cancer risk: a population-based case-control study in Slovakia.
Zúbor P; Vojvodová A; Danko J; Kajo K; Szunyogh N; Lasabová Z; Biringer K; Visnovský J; Dókus K; Galajda P; Plank L
Neoplasma; 2006; 53(1):49-55. PubMed ID: 16416013
[TBL] [Abstract][Full Text] [Related]
15. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
[TBL] [Abstract][Full Text] [Related]
16. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
